SMIM
3.113,10
PKT
+17,00
PKT
+0,55
%
Werbung
Analysen zu SMIM-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 31.10.12 | Clariant buy | Sarasin Research | |
| 31.10.12 | Barry Callebaut hold | Vontobel Research | |
| 30.10.12 | Straumann underperform | Cheuvreux SA | |
| 30.10.12 | Straumann neutral | Sarasin Research | |
| 30.10.12 | Adecco SA buy | Vontobel Research | |
| 30.10.12 | Straumann hold | Vontobel Research | |
| 29.10.12 | Swatch (I) buy | Goldman Sachs Group Inc. | |
| 29.10.12 | Schindler hold | Vontobel Research | |
| 29.10.12 | Julius Bär buy | UBS AG | |
| 29.10.12 | SGS SA buy | Vontobel Research | |
| 26.10.12 | Clariant buy | Vontobel Research | |
| 26.10.12 | SGS SA buy | Vontobel Research | |
| 25.10.12 | Straumann underperform | Exane-BNP Paribas SA | |
| 25.10.12 | Schindler neutral | Exane-BNP Paribas SA | |
| 24.10.12 | Temenos underperform | Cheuvreux SA | |
| 24.10.12 | Temenos equal-weight | Morgan Stanley | |
| 24.10.12 | Temenos outperform | Exane-BNP Paribas SA | |
| 24.10.12 | Roche buy | Sarasin Research | |
| 24.10.12 | Temenos buy | Vontobel Research | |
| 24.10.12 | SGS SA buy | Vontobel Research | |
| 23.10.12 | Barry Callebaut underperform | Cheuvreux SA | |
| 23.10.12 | Schindler outperform | Cheuvreux SA | |
| 23.10.12 | SGS SA outperform | Cheuvreux SA | |
| 23.10.12 | ams-OSRAM buy | UBS AG | |
| 23.10.12 | Avolta (ex Dufry) buy | Vontobel Research | |
| 23.10.12 | Barry Callebaut hold | Vontobel Research | |
| 23.10.12 | Schindler buy | Sarasin Research | |
| 23.10.12 | Barry Callebaut neutral | Sarasin Research | |
| 23.10.12 | ams-OSRAM buy | Vontobel Research | |
| 23.10.12 | Schindler hold | Vontobel Research | |
| 22.10.12 | Adecco SA neutral | UBS AG | |
| 18.10.12 | Roche outperform | Credit Suisse Group | |
| 18.10.12 | Julius Bär equal-weight | Morgan Stanley | |
| 18.10.12 | Roche overweight | J.P. Morgan Cazenove | |
| 18.10.12 | Straumann hold | Vontobel Research | |
| 18.10.12 | Roche halten | Hamburger Sparkasse AG (Haspa) | |
| 17.10.12 | Roche outperform | Exane-BNP Paribas SA | |
| 16.10.12 | Roche outperform | Cheuvreux SA | |
| 16.10.12 | Roche buy | Banc of America Securities-Merrill Lynch | |
| 16.10.12 | Clariant buy | Vontobel Research |